Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Jefferies Financial
JEF
5
Bank of America
BAC
CN Stock MarketDetailed Quotes
603566 Pulike Biological Engineering,Inc.
- 14.04
- +0.50+3.69%
Not Open May 15 15:00 CST
4.86BMarket Cap41.05P/E (TTM)
14.29High13.45Low159.54KlotVolume13.54Open13.54Pre Close222.79MTurnover4.61%Turnover Ratio52.39P/E (Static)346.06MShares24.6052wk High1.81P/B4.86BFloat Cap10.8052wk Low14.89Limit Up346.06MShs Float40.48Historical High12.19Limit Down6.20%Amplitude8.36Historical Low0.40Dividend TTM13.96Avg Price68.49KlotAsk2.85%Div YieldTTM100Lot Size86.36KlotBid
Pulike Biological Engineering,Inc. Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 18.32%278.62M | -16.77%1.04B | -17.96%761.74M | -21.82%483.15M | -23.27%235.49M | 1.84%1.25B | 12.25%928.54M | 20.53%617.98M | 25.12%306.91M | 11.97%1.23B |
| Operating revenue | 18.32%278.62M | -16.77%1.04B | -17.96%761.74M | -21.82%483.15M | -23.27%235.49M | 1.84%1.25B | 12.25%928.54M | 20.53%617.98M | 25.12%306.91M | 11.97%1.23B |
| Other operating revenue | ---- | -14.09%8.69M | ---- | -33.22%4.4M | ---- | -22.59%10.11M | ---- | 33.99%6.59M | ---- | 18.48%13.06M |
| Total operating cost | 6.43%218.37M | -10.57%939.85M | -11.46%654.45M | -15.49%406.84M | -14.88%205.18M | 1.54%1.05B | 9.81%739.13M | 16.48%481.44M | 20.79%241.06M | 19.42%1.03B |
| Operating cost | 33.93%112.25M | -16.95%405.63M | -21.13%280.73M | -25.11%177.88M | -33.79%83.81M | 6.23%488.4M | 15.64%355.93M | 22.68%237.52M | 35.27%126.58M | 21.00%459.74M |
| Operating tax surcharges | 12.18%4.42M | 13.53%16.6M | 15.37%12.25M | 13.00%7.94M | 6.73%3.94M | 14.49%14.62M | 20.60%10.62M | 24.42%7.02M | 32.94%3.69M | 13.07%12.77M |
| Operating expense | -2.09%62.08M | -16.08%295.42M | -17.04%209.78M | -18.34%134.37M | -17.47%63.4M | -4.12%352.03M | 5.06%252.88M | 13.15%164.54M | 17.94%76.82M | 22.37%367.16M |
| Administration expense | -44.70%18.95M | 20.64%118.23M | 37.58%84.17M | 31.95%44.89M | 106.97%34.27M | -8.05%98M | -10.65%61.18M | -25.78%34.02M | -26.28%16.56M | 16.05%106.58M |
| Financial expense | 63.81%-255.65K | 35.89%-2.07M | 43.81%-1.48M | 10.90%-1.19M | -1,793.07%-706.4K | 18.22%-3.23M | -32.57%-2.63M | -84.71%-1.33M | 80.76%-37.31K | -91.71%-3.94M |
| -Interest expense (Financial expense) | ---- | -91.00%82.97K | ---- | ---- | ---- | 7.36%922.16K | 23.73%823.64K | 78.60%770.96K | 688.80%763.05K | --858.98K |
| -Interest Income (Financial expense) | 33.39%-401.03K | 48.02%-2.14M | 48.05%-1.69M | 40.07%-1.1M | 46.80%-602.02K | 7.34%-4.13M | -67.33%-3.25M | -95.77%-1.84M | -307.61%-1.13M | -78.10%-4.45M |
| Research and development | 2.24%20.92M | 4.90%106.05M | 12.81%68.99M | 8.27%42.95M | 17.31%20.46M | 9.15%101.1M | 24.08%61.16M | 68.40%39.67M | 10.37%17.44M | 8.24%92.62M |
| Credit Impairment Loss | 36.41%520.82K | 119.57%4.67M | -76.09%1.36M | -86.54%233.22K | -86.93%381.82K | -19.56%-23.86M | 171.67%5.67M | 128.09%1.73M | 180.89%2.92M | -142.12%-19.96M |
| Asset Impairment Loss | --374.1K | -3,018.27%-1M | ---1.16M | ---792.73K | ---- | ---32.22K | ---- | ---- | ---427.88K | ---- |
| Other net revenue | 87.09%1.64M | 43.90%-4.92M | -7.90%8.29M | 167.28%4.07M | -90.72%875.76K | 51.90%-8.77M | 168.90%9M | 19.99%-6.05M | 326.89%9.44M | -134.62%-18.22M |
| Fair value change income | 98.27%-44.73K | 43.66%-9.97M | 83.61%-4.92M | 79.72%-4.79M | 40.70%-2.59M | 30.81%-17.69M | -806.44%-30M | -829.86%-23.63M | -2,309.15%-4.36M | -225.28%-25.57M |
| Invest income | -290.21%-1.48M | -84.97%2.66M | -68.51%6.5M | -42.97%5.32M | -89.49%777.05K | 213.20%17.66M | 247.24%20.63M | 225.77%9.33M | 847.40%7.4M | 35,699.90%5.64M |
| -Including: Investment income associates | -485.55%-3.42M | -33.04%-11.79M | -269.46%-4.22M | -428.84%-2.95M | -151.27%-583.8K | 55.97%-8.86M | 114.50%2.49M | 94.51%-557.44K | 130.58%1.14M | -140.30%-20.13M |
| Asset deal income | -629.06%-58.39K | -2,696.78%-11.35M | -171.04%-132.31K | -38.38%-72.74K | -48.67%-8.01K | -96.80%-405.91K | -4,937.17%-48.82K | -271.47%-52.57K | -111.07%-5.39K | 71.10%-206.26K |
| Other revenue | 0.62%2.32M | -35.18%10.08M | -47.82%6.65M | -36.56%4.18M | -40.95%2.31M | -28.86%15.56M | 4.76%12.75M | -22.91%6.58M | 581.25%3.91M | -46.94%21.87M |
| Operating profit | 98.46%61.89M | -49.33%97.79M | -41.74%115.59M | -38.40%80.38M | -58.58%31.19M | 9.10%193.01M | 40.63%198.41M | 42.13%130.49M | 81.10%75.29M | -37.83%176.92M |
| Add:Non operating Income | 116.11%407.93K | 14.14%2.48M | 35.36%1.97M | 1,765.02%1.9M | 140.50%188.76K | -4.27%2.17M | 4,408.85%1.46M | 376.78%101.71K | 7,008.52%78.49K | -11.02%2.27M |
| Less:Non operating expense | -71.66%87.74K | 163.33%1.51M | -50.00%441.87K | 174.60%408.69K | 17,015.69%309.65K | -60.93%571.59K | 7.28%883.74K | -24.31%148.83K | -91.10%1.81K | -50.51%1.46M |
| Total profit | 100.26%62.21M | -49.25%98.76M | -41.14%117.12M | -37.24%81.87M | -58.78%31.06M | 9.51%194.61M | 41.83%198.99M | 42.35%130.45M | 81.37%75.37M | -37.46%177.72M |
| Less:Income tax cost | 147.59%9.3M | -70.35%5.96M | -45.44%10.84M | -44.99%7.92M | -66.82%3.76M | 102.99%20.1M | 63.42%19.88M | 26.52%14.4M | 181.03%11.33M | -75.27%9.9M |
| Net profit | 93.75%52.91M | -46.82%92.81M | -40.67%106.27M | -36.28%73.95M | -57.36%27.31M | 3.99%174.52M | 39.78%179.11M | 44.59%116.05M | 70.67%64.04M | -31.26%167.82M |
| Net profit from continuing operation | 93.75%52.91M | -46.82%92.81M | -40.67%106.27M | -36.28%73.95M | -57.36%27.31M | 3.99%174.52M | 39.78%179.11M | 44.59%116.05M | 70.67%64.04M | -31.26%167.82M |
| Net profit of parent company owners | 93.75%52.91M | -46.82%92.81M | -40.67%106.27M | -36.28%73.95M | -57.36%27.31M | 3.99%174.52M | 39.78%179.11M | 44.59%116.05M | 70.67%64.04M | -31.26%167.82M |
| Earning per share | ||||||||||
| Basic earning per share | 100.00%0.16 | -46.00%0.27 | -40.38%0.31 | -38.24%0.21 | -57.89%0.08 | -3.85%0.5 | 26.83%0.52 | 30.77%0.34 | 58.33%0.19 | -33.33%0.52 |
| Diluted earning per share | 100.00%0.16 | -46.00%0.27 | -40.38%0.31 | -38.24%0.21 | -57.89%0.08 | -3.85%0.5 | 26.83%0.52 | 30.77%0.34 | 58.33%0.19 | -33.33%0.52 |
| Other composite income | ||||||||||
| Total composite income | 93.75%52.91M | -46.82%92.81M | -40.67%106.27M | -36.28%73.95M | -57.36%27.31M | 3.99%174.52M | 39.78%179.11M | 44.59%116.05M | 70.67%64.04M | -31.26%167.82M |
| Total composite income of parent company owners | 93.75%52.91M | -46.82%92.81M | -40.67%106.27M | -36.28%73.95M | -57.36%27.31M | 3.99%174.52M | 39.78%179.11M | 44.59%116.05M | 70.67%64.04M | -31.26%167.82M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting